๐ŸŽ—๏ธ OncologyInjectable

    Carmustine

    carmustine

    Nitrosourea alkylating agent used as palliative therapy for brain tumors, multiple myeloma, Hodgkin disease, and non-Hodgkin lymphomas.

    Form

    Injectable

    Uses

    3

    Side effects

    4

    Category

    Oncology

    01

    What is Carmustine used for?

    • Palliative treatment of brain tumors including glioblastoma multiforme
    • Treatment of multiple myeloma and Hodgkin disease
    • Treatment of non-Hodgkin lymphomas refractory to primary therapy
    02

    carmustine side effects

    The following side effects have been reported for carmustine. Their order does not indicate how often an effect occurs.

    Bone marrow suppression
    Nausea and vomiting
    Pulmonary fibrosis
    Hepatotoxicity
    03

    carmustine warnings & precautions

    • Delayed bone marrow suppression can occur 4 to 6 weeks after a dose
    • Monitor pulmonary function; risk of pulmonary fibrosis increases with cumulative dose

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Carmustine in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.